These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 497566)

  • 1. Chlorimipramine-induced phospholipidosis: biochemical and pharmacokinetic observations [proceedings].
    Della Corte L; Gremigni D; Megazzini I; Mobilio R; Sgaragli GP
    Br J Pharmacol; 1979 Nov; 67(3):449P-450P. PubMed ID: 497566
    [No Abstract]   [Full Text] [Related]  

  • 2. Chlorimipramine-induced phospholipidosis: biochemical and pharmacokinetic observations in the rat.
    Sgaragli GP; Della Corte L; Gremigni D
    Pharmacol Res Commun; 1983 Mar; 15(3):231-46. PubMed ID: 6856656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phospholipidosis of the rat lung following administrations of chlorimipramine].
    Gremigni D; Vannelli G; Sgaragli G; Della Corte L
    Arch Ital Anat Embriol; 1981; 86(1-2):37-53. PubMed ID: 7316635
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of drug-induced phospholipidosis on pulmonary disposition of pneumophilic drugs.
    Ohmiya Y; Angevine LS; Mehendale HM
    Drug Metab Dispos; 1983; 11(1):25-30. PubMed ID: 6132791
    [No Abstract]   [Full Text] [Related]  

  • 5. [Phospholipidosis induced by chlorimipramine in rat lung].
    Gremigni D; Vannelli G; Sgaragli GP; Mengazzini I
    Boll Soc Ital Biol Sper; 1980 May; 56(10):1078-82. PubMed ID: 7448010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced phospholipidosis.
    Anderson N; Borlak J
    FEBS Lett; 2006 Oct; 580(23):5533-40. PubMed ID: 16979167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental phospholipidosis induced by 4,4'-diethyl-aminoethoxyhexestrol. Morphological and biochemical interpretations.
    Tashiro Y; Watanabe Y; Enomoto Y
    Acta Pathol Jpn; 1983 Sep; 33(5):929-42. PubMed ID: 6316720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled cationic amphiphilic drug-induced pulmonary phospholipidosis in rats and dogs: time-course and dose-response of biomarkers of exposure and effect.
    Pauluhn J
    Toxicology; 2005 Feb; 207(1):59-72. PubMed ID: 15590122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphological, histochemical and biochemical changes induced by homochlorcyclizine in the rat].
    Lageron A; Saffroy M
    Acta Histochem; 1982; 71(1):103-10. PubMed ID: 6128854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lead-induced phospholipidosis and cholesterogenesis in rat tissues.
    Ademuyiwa O; Agarwal R; Chandra R; Behari JR
    Chem Biol Interact; 2009 May; 179(2-3):314-20. PubMed ID: 19056365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipidosis in nonclinical toxicity studies.
    Berridge BR; Chatman LA; Odin M; Schultze AE; Losco PE; Meehan JT; Peters T; Vonderfecht SL;
    Toxicol Pathol; 2007 Feb; 35(2):325. PubMed ID: 17366328
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical characteristics of rat alveolar macrophages with chlorphentermine-induced phospholipidosis: variations with increasing cell size.
    Reasor MJ; Koshut RA; Castranova V
    Exp Mol Pathol; 1979 Oct; 31(2):297-307. PubMed ID: 467619
    [No Abstract]   [Full Text] [Related]  

  • 13. [Secondary phospholipidosis caused by 4.4'-diethylaminoethoxy hexestrol].
    Shikata T
    Rinsho Byori; 1973 May; 21(5):389-94. PubMed ID: 4738035
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and experimental studies on phospholipidosis caused by diethylaminoethoxyhexestrol(DH)].
    Tsujii T; Matsumori T; Takahashi M; Sugioka T; Matsui T
    Saishin Igaku; 1971 Nov; 26(11):2242-50. PubMed ID: 5141966
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of a pre-existing phospholipidosis on the accumulation of amiodarone and desethylamiodarone in rat alveolar macrophages.
    Reasor MJ
    Res Commun Chem Pathol Pharmacol; 1991 May; 72(2):169-81. PubMed ID: 1876748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological and biochemical changes in the liver of various species in experimental phospholipidosis after diethylaminoethoxyhexestrol treatment.
    de la Iglesia FA; Feuer G; McGuire EJ; Takada A
    Toxicol Appl Pharmacol; 1975 Oct; 34(1):28-44. PubMed ID: 1198614
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of phospholipidosis induction: a cell-based assay in high-throughput and high-content format.
    Shahane SA; Huang R; Gerhold D; Baxa U; Austin CP; Xia M
    J Biomol Screen; 2014 Jan; 19(1):66-76. PubMed ID: 24003057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Case of phospholipidosis considered to be caused by orally administered diethylaminoethoxyhexestrol(DH)].
    Takino T; Sakai Y; Shinraku M; Tanizawa Y; Hashimoto S
    Saishin Igaku; 1971 Nov; 26(11):2241-2. PubMed ID: 5141965
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages.
    McCloud CM; Beard TL; Kacew S; Reasor MJ
    Exp Mol Pathol; 1995 Feb; 62(1):12-21. PubMed ID: 7556587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes.
    Ikeda K; Hirayama M; Hirota Y; Asa E; Seki J; Tanaka Y
    Biochem Biophys Res Commun; 2008 Dec; 377(1):268-74. PubMed ID: 18840403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.